Order Article Reprints

Krupa P, Vackova I, Ruzicka J, Zaviskova K, Dubisova J, Koci Z, Turnovcova K, Urdzikova LM, Kubinova S, Rehak S, et al. The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application. International Journal of Molecular Sciences. 2018; 19(5):1503. https://doi.org/10.3390/ijms19051503

Krupa, Petr, Irena Vackova, Jiri Ruzicka, Kristyna Zaviskova, Jana Dubisova, Zuzana Koci, Karolina Turnovcova, Lucia Machova Urdzikova, Sarka Kubinova, Svatopluk Rehak, and et al. 2018. "The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application" International Journal of Molecular Sciences 19, no. 5: 1503. https://doi.org/10.3390/ijms19051503

Krupa, P., Vackova, I., Ruzicka, J., Zaviskova, K., Dubisova, J., Koci, Z., Turnovcova, K., Urdzikova, L. M., Kubinova, S., Rehak, S., & Jendelova, P. (2018). The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application. International Journal of Molecular Sciences, 19(5), 1503. https://doi.org/10.3390/ijms19051503